Juliette LAMBERT
Versailles Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Juliette LAMBERT as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05199051 · A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AMLCentre Antoine Lacassagne · active not recruiting · AML, Leukaemia (Acute Myeloid) · principal investigator
- Ph2/Ph3NCT02473146 · Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4Versailles Hospital · completed · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:20 UTC. The ranking covers the 200 most relevant of 224 PubMed records, and a shared surname and initials can bring in a namesake. All 224 on PubMed
- 1,211 citationsRCR 32.3
- 854 citationsRCR 35.4
- Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.N Engl J Med · 1999382 citationsRCR 10.7
- Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.Clin Infect Dis · 2010333 citationsRCR 10.3
- Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.Haematologica · 2019308 citationsRCR 11.6
- 304 citationsRCR 9.6
- Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study.Circulation · 2004284 citationsRCR 7.6
- Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas.J Natl Cancer Inst · 1995231 citationsRCR 7.0
- Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial.Am J Respir Crit Care Med · 2010218 citationsRCR 5.7
- Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease.Am J Hum Genet · 2016218 citationsRCR 6.2